Common use of Milestone Event Milestone Payment Clause in Contracts

Milestone Event Milestone Payment. First [**] from the [**] for a for each [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of clause (a) of Section 1.15 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event on the basis of clause (a) of Section 1.15 [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.5 and Milestone Event B.1 above on the basis of clause (ab) of Section 1.15 and from 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.5 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (ab) of Section 1.15 and from 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] ]Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (ab) of Section 1.15 and from but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each subsequent Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 and Milestone Event D.7 above on the basis of clause (ab) of Section 1.15 and from 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event D.3 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of clause (a) of Section 1.15 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event on the basis of clause (a) of Section 1.15 [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of clause (ab) of Section 1.15 and from 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from the [**] Acceptance for a for each [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.2 above on the basis of clause (a) of Section 1.15 and from the Class of [**] ]Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event on the basis of clause (a) of Section 1.15 [**]

Milestone Event Milestone Payment. First [**] from with the [**] for a for each subsequent Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 and Milestone Event D.7 above on the basis of clause (ab) of Section 1.15 and from 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event D.3 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of clause (ab) of Section 1.15 and from but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event on the basis of clause (a) of Section 1.15 [**]

Milestone Event Milestone Payment. First [**] from the [**] Acceptance for a for each [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.2 above on the basis of clause (a) of Section 1.15 1.21 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event on the basis of clause (a) of Section 1.15 1.21 [**]

Milestone Event Milestone Payment. First [**] from the [**] Acceptance for a for each [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.2 above on the basis of clause (a) of Section 1.15 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event on the basis of clause (a) of Section 1.15 [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of clause (a) of Section 1.15 1.21 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event on the basis of clause (a) of Section 1.15 1.21 [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (ab) of Section 1.15 and from but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.5 above on the basis of clause (ab) of Section 1.15 and from 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.5 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of clause (ab) of Section 1.15 and from but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from the [**] Acceptance for a for each [**] Engineered T-Cell Product that differs from the Class of [**] ]Engineered T-Cell Product that was the subject of Milestone Event A.4 A.2 above on the basis of clause (a) of Section 1.15 1.21 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event on the basis of clause (a) of Section 1.15 1.21 [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each subsequent Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 and Milestone Event D.7 above on the basis of clause (ab) of Section 1.15 and from but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event D.3 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of clause (ab) of Section 1.15 and from but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event D.3 above on the basis of clause (a) of Section 1.15 Gene Target [**]

Milestone Event Milestone Payment. First [**] from filing with the [**] for a for each Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of clause (ab) of Section 1.15 and from 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event D.3 above on the basis of clause (a) of Section 1.15 Gene Target [**]